r Recurrent periods of over-excitation in the paraventricular nucleus (PVN) of the hypothalamus could contribute to chronic over-activation of this nucleus and thus enhanced sympathetic drive.
Introduction
Hypertension is one of the most prevalent conditions observed in health care, with 46% of the US adult population affected by the disease, showing complex aetiology including an overactive sympathetic tone (Whelton et al. 2018 ). Blood pressure (BP) and cardiac output are continuously adjusted by the central nervous system (CNS) to match the fluctuating metabolic requirements of behaviour. These rapid adjustments occur almost entirely via changes in sympathetic and cardio-vagal efferent activity (Guyenet, 2006) . Mean (24 h average) BP, however, is maintained within relatively narrow limits by the kidneys via blood volume control and by the properties of blood vessels. Mean BP is also influenced by the sympathetic nervous system and many forms of hypertension are currently presumed to be partly caused by excessive sympathetic tone (Esler et al. 2001) . Sympathetic drive is determined by a vast network of neurons that converge on a limited number of pre-sympathetic neurons including those in the hypothalamic paraventricular nucleus (PVN), brainstem and spinal cord that directly innervate sympathetic preganglionic neurons (Swanson, 1977; Samson et al. 2007; Marina et al. 2011; Guyenet et al. 2013) . The hypothalamus modulates a myriad of body functions, including cardiovascular control, metabolic regulation, body temperature, and sexual and feeding behaviours (Saper & Lowell, 2014) . The role of the PVN in the central regulation of BP and autonomic function is well established (Zhang et al. 2002; Shi et al. 2010; Sriramula et al. 2011) . The PVN assimilates inputs from circumventricular nuclei that contain osmo-sensitive neurons (e.g. subfornical organ) and the nucleus of the solitary tract (NTS) relaying them down to multiple areas including the rostral ventrolateral medulla (RVLM) in the brainstem (Geerling et al. 2010; Stocker et al. 2013) . The RVLM, an integral part of sympathetic output relay, is thought to be the main recipient of these PVN outputs (Esler et al. 2001) .
The degree to which the PVN contributes to BP both at baseline and in hypertensive conditions in conscious mammals still requires investigation. The vast majority of studies up to this point focus on the hypothalamic-hormonal contribution from neurons in this part of the brain (Geraldes et al. 2014; Vivas et al. 2014; Brown, 2016; Lozic et al. 2018) . However, there is a growing body of evidence suggesting a role for the PVN in more immediate sympathetic nervous system regulation (Guyenet, 2006) . It has been shown that in anaesthetized and reduced preparations, i.e. experiments that isolate one part of the system/network being studied to decrease the variables involved, the PVN plays an important role in BP regulation (Kc & Dick, 2010; Gomes da Silva et al. 2012) . Pharmacological interventions activating PVN neurons or inhibiting GABAergic neurons of the PVN cause an increase in BP and an observed increase in sympathetic nerve activity (Li et al. 2001; Gabor & Leenen, 2012; Gomes da Silva et al. 2012 ). This activation is presumably functioning through the glutamatergic neuronal population in the PVN projecting to the RVLM but this remains to be validated in conscious animals (Geerling et al. 2010) . Glutamate, a well-known excitatory neurotransmitter in the CNS, has been studied and found to be functionally relevant in the PVN (Miyawaki et al. 1996; Butcher & Cechetto, 1998) . More specifically, in pharmacological studies where NMDA receptors of the PVN are activated unambiguously, sympathetic nerve activity increases, thus affecting the BP (Li et al. 2001) . Accordingly, we hypothesize that increased central sympathetic drive is caused by chronic over-excitation of glutamatergic PVN neurons during the development of neurogenic hypertension. This was examined in two ways using conscious mice, through selective activation of this neuronal population with channelrhodopsin-2 (ChR2) and secondly, through selective destruction of the same population. We find that unilateral activation of the glutamate population of PVN neurons is sufficient to drive an increase in BP similar to that seen during hypertension. Moreover, loss-of-function experiments demonstrate impaired baroreflex function, attenuated BP rise and decreased sympathetic outflow during DOCA-salt hypertension.
Methods

Animals
Experiments were performed on male and female C57Bl6/J mice (n = 35; 20-35 g) or vGlut2-Cre mice (B6J.129S6(FVB)-Slc17a6tm2(cre)Lowl/MwarJ that were mated with CAG-tdTomato reporter mice (B6.CgGt(ROSA)26Sortm14(CAG-tdTomato)Hze/J (Jackson Laboratories, Bar Harbor, ME, USA). All mice were on a C57Bl6/J background. All procedures conformed to the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Louisiana State University Health Sciences Center Animal Care and Use Committee. Animals were housed under a standard 12 h light/dark cycle with ad libitum access to food and water.
Viral constructs and virus preparation
For experiments on conscious mice, two different adeno-associated viral vectors (AAVs) were used. The first expresses the photoactivatable cation channel channelrhodopsin-2 (ChR2) under the calcium/ calmodulin-dependent protein kinase type II α (CaMKIIα) promoter (AAV-CamKIIα-ChR2-eYFP serotype 2) (courtesy of Dr Karl Deisseroth, Stanford Univ., CA, USA). The CamKIIα promoter has been shown to be selective for glutamate neurons in the thalamic neuronal populations (Liu & Jones, 1996; Wang et al. 2013; Watakabe et al. 2015) . The AAV-flex-taCasp3-TEVp (courtesy of Dr N. Shah, Univ. of Arkansas, AR, USA) was used for lesion experiments, performed on vesicular glutamate2 cre-recombinase (vGlut2-Cre) mice. Viral vectors were obtained from the University of North Carolina virus core. The ChR2 and Caspase AAV2s were used at concentrations of 5.2 × 10 12 and 1.8 × 10 12 viral particles/ml, respectively.
Injections of vectors and mouse instrumentation
Mice were anaesthetized with 1.5-2% isoflurane in an oxygen flow (1 l/min). Depth of anaesthesia was assessed by absence of corneal and hindpaw withdrawal reflexes. Body temperature was kept near 37°C with a heating pad (WPI Inc. Sarasota, FL, USA) and blanket.
The AAVs were microinjected into the PVN using a stereotaxic approach. The mouse was placed prone on a Stoelting stereotaxic frame making sure the skull lay flat. A 1.5 mm-diameter hole was drilled into the parietal plate on the left or both sides caudal to bregma. Unilateral microinjections were performed on mice receiving the AAV-CamKIIα-ChR2-eYFP and bilaterally on those receiving the AAV-flex-taCasp3-TEVp. Viral vectors were loaded into a 1.2 mm internal diameter glass pipette broken to 25 μm tip (external diameter). Each AAV was injected into three rostro-caudally aligned sites separated by 200 μm resulting in a total volume of 400-600 nl/side (ß200 nl/injection site). Stereotaxic coordinates of PVN microinjections were 0.3 mm lateral, 0.6 mm caudal and 4.5 mm ventral. In animals that received the unilateral microinjections of AAV-CamKIIα-ChR2-eYFP, an optical fibre was then implanted for light stimulation. Optical fibres (125 μm; Thorlabs, Newton, NJ, USA) were fitted with ferrules, as previously described (Sparta et al. 2011) and implanted into the PVN with the tip 0.5 mm dorsal to the vector injection site during the same surgery period. The optic-ferrule assembly was secured to the skull using a two-part epoxy adhesive (Loctite). Incisions were then closed with absorbable sutures and Vetbond adhesive. Mice received postoperative Buprenorphine SR (0.5 mg/kg subcutaneously) and penicillin (600-1000 UI/10 g I.M.) and were monitored daily. No sham operations were performed for this study. Previous work shows injections of AAV alone do not affect BP (Basting et al. 2015) . Mice were given gel food, allowed to recover for a minimum of 5 weeks for the ChR2 and 2 weeks for the caspase and then implanted with a radio-telemetry probe (PA-C10, Data Sciences International (DSI), St Paul, MN, USA) to record BP via the left carotid artery. Spontaneous baroreceptor reflex sensitivity (SBRS), reflecting the baroreflex control of heart rate, was calculated using the sequence method as described previously (Stauss et al. 2006) . These mice were allowed to recover for an additional week before physiological experiments began.
Optogenetic experiments in conscious mice
On the day of the experiment, mice were lightly anaesthetized with isoflurane (2% in an oxygen flow (1 l/min) for <1 min) to allow cleaning of hardware and connection of the ferrule to the laser. A 125 μm-thick multimode optical fibre, terminated with a ferrule, was mated to the implanted ferrule with a zirconium sleeve. Optical matching gel (Fibre Instrument Sales, Oriskany, NY, USA) was applied at the junction of the ferrules to reduce light loss. A minimum of 45 min was allowed for recovery from anaesthesia.
Photoexcitation of ChR2-expressing PVN neurons was achieved with a blue laser (473 nm, Shanghai Laser and Optics Century, Shanghai, China). The Laser was controlled using an A300 model stimulator (WPI Inc., Sarasota, FL, USA). Blue light was pulsed for 10 s at 2, 10 or 20 Hz, in a randomized fashion, with a pulse-width of 20 ms at ß9 mW of light output at the tip. The J Physiol 596.24 transmission efficiency of each implanted optical fibre was tested before implantation with a light power meter (Thorlabs, Newton, NJ, USA). A minimum of five photoactivation trials were conducted in each mouse, at each stimulation frequency level. Average BP values were extracted from all trials not influenced by body movements, as indicated by BP recording and observation. Cardiovascular parameters (BP, heart rate) were averaged during the 10 s photostimulus. Baseline values were measured during the 20 s preceding light delivery.
DOCA-salt protocol
For each surgery, the mouse was anaesthetized with isoflurane, placed on a heating pad to maintain body temperature and received postoperative care as described above.
Baseline BP was recorded, using DSI Ponemah software and radio telemetry probes (PA-C10), in uni-nephrectomized mice after a week of recovery (Xia et al. 2013) . Mice undergoing the DOCA-salt treatment were implanted subcutaneously with a DOCA-silicone pellet (DOCA-silicone = 1:3; DOCA: 1 mg/g body weight) a week after being uni-nephrectomized. Drinking water was switched to 1% NaCl solution. BP was recorded for three additional weeks. All recordings were done for a continuous hour-long period between 09.00 and 11.00 h depending on the day.
Western blot
After the animal was killed by ketamine/xylazine overdose, the brain was rapidly extracted and frozen on dry ice. The RVLM was identified (−7.0 mm to −6.0 mm relative to bregma) and dissected grossly (Franklin & Paxinos, 1997) . Tissues were suspended in 200 μl lysis buffer per sample (Cell Lysis Buffer 1, cat. no. 890713; R&D Systems, Minneapolis, MN, USA) containing a protease inhibitor cocktail (cat. no. 4693159001; Sigma, St Louis, MO, USA). Tissue was sonicated and centrifuged at 4°C and whole-protein supernatant was collected. Protein concentration was measured via bicinchoninic acid (BCA) assay (cat. no. 23225; Pierce, Rockford, IL, USA). Lysate samples with equal amounts of protein were prepared via dilution in lysis buffer. Lysate samples were mixed with SDS-PAGE sample buffer and boiled at 95°C for 5 min. Samples were loaded on a 4-15% SDS-polyacrylamide gel for electrophoresis at 80 V for 40 min, followed by 120 V for 30 min (cat. no. 456-1086; Bio-Rad, Hercules, CA, USA). Proteins were transferred to a nitrocellulose membrane on ice at 100 V for 1 h (cat. no. 162-0115; Bio-Rad). The membrane was washed once for 15 min and 3 times for 5 min each in Tris buffered saline with Tween 20 (TBST) prior to 1 h incubation in a 5% non-fat milk and 0.01% w/v thimerosal in TBST (cat. no. AAJ77500K8; Fisher Scientific, Houston, TX, USA) prior to overnight incubation with anti-tumor necrosis factor receptor 1 (anti-TNF-R1) (1:1000, cat. no. sc-8436; Santa Cruz Biotechnology, Santa Cruz, CA, USA). Membranes were washed once for 15 min and 3 times for 5 min in TBST, then incubated with goat anti-mouse immunoglobulin G (IgG)-horseradish peroxidase (HRP) in blocking buffer (1:10,000, cat. no. NEF822001EA; Perkin Elmer, Waltham, MA, USA) for 1 h at room temperature. Bands were developed via chemiluminescence after HRP activation with an ECL reagent (cat. no. RPN2232; GE Healthcare UK, Little Chalfont, UK). Bands were detected and densitized using the commercial Amersham Imager 600 hardware and software (cat. no. 29083461; GE Healthcare Bio-Sciences AB, Uppsala, Sweden).
For the loading control, the membrane was washed 1 × 15 min and 3 × 5 min in TBST before re-probing with a mixed primary/secondary/blocking buffer solution (2 h incubation with 1:1000 rabbit-anti-GAPDH, cat. no. 14C10; Cell Signaling, Danvers, MA, USA and 1:5000 HRP-conjugated goat-anti-rabbit, cat. no. NA934vs; GE Healthcare UK, Little Chalfont, UK). Loading control bands were imaged on the same Amersham imaging system listed above.
Urine noradrenaline, gene expression and serum copeptin
Urine was collected from both controls and mice with bilateral PVN lesions before and after the DOCA-salt protocol. Noradrenaline (norepinephrine; NE) levels were measured as an index of sympathetic activity, using a noradrenaline enzyme-linked immunosorbent assay (ELISA) kit (IB89552; Immuno-Biological Laboratories, Minneapolis, MN, USA) according to the manufacturer's instructions. The optical density was measured with a photometer at 405 nm (reference wavelength: 620-650 nm). Each 10 μl sample was measured in duplicate.
Total RNA was isolated from the RVLM using RNeasy Plus Micro Kit (Qiagen, Waltham, MA, USA). Real time PCR amplification reactions were performed with SYBR Green Master mix (Roche, Mannheim, Germany) using a Real time PCR machine (Roche LightCycler 480). Data were normalized to β-actin expression by the 2
Blood serum copeptin levels were measured in controls and mice with bilateral PVN lesions (Cloud-Clone Corp., Katy, TX, USA, ELISA kit: CEA365Mu). Each sample was collected by sub-mandibular puncture of the facial vein.
Histology
Animals were deeply anaesthetized with a ketamine (100 mg/kg)/xylazine (10 mg/kg) mix and transcardially perfused with 4% paraformaldehyde in PBS. The brain was removed and sectioned at 20 μm-thick slices of the PVN, collected in a cryostat and mounted for further analysis. The PVN was defined according to Paxinos and Franklin's Mouse Brain Atlas from anterior to posterior relative to bregma (+0.5 to −1.22 mm) (Franklin & Paxinos, 1997) . Cell mapping, counting and photography were done using the Leica LASX software with a Leica DMi8 microscope. A gold/yellow filter was used (Fig. 4) 
Results
ChR2 stimulation of the PVN in conscious mice
To determine unequivocally whether activation of PVN neurons is sufficient to drive a change of BP in conscious, freely moving mice, this region was transfected with an AAV expressing ChR2. Five to 6 weeks after injection, the PVN neurons were activated in conscious freely moving mice. Stimulations were performed in the home cage when the mice were calm and quietly awake. The stimulation did not have an observable effect on behaviour. Figure 1 shows that ChR2 stimulation with blue light (473 nm) at 2 Hz (20 ms pulses) had no effect on BP (P > 0.05). However, when the frequency of stimulation increased, the BP rose significantly at both 10 Hz, with systolic BP rise equal to 4.7 ± 1.9 mmHg (P < 0.01), and 20 Hz, with systolic BP rise equal to 8.5 ± 2.2 mmHg (P < 0.001). Quantitative results recorded from seven mice undergoing PVN neuron stimulation showed a frequency-dependent effect ( Fig. 1) with BP rising as frequency of stimulation increased.
Resting heart rate did not change statistically (2, 10 and 20 Hz, P > 0.05) although two out of the seven mice exhibited a dramatic bradycardia following PVN activation at the highest frequency of light stimulation.
Immunohistochemistry
In order to confirm the location of the ChR2-transfected CamKIIα neurons to the PVN, immunohistochemistry was performed, taking advantage of the AAV2-CamKIIα-ChR2 fused with enhanced yellow fluorescent protein (eYFP) (Fig. 2) . The data shown in Fig. 2 are from a mouse in the same group of animals used in the optogenetic stimulation experiments. Figure 2A and B shows transfection to the PVN while surrounding nuclei, such as the subfornical organ (SFO) (Fig. 2C ) and arcuate nucleus (Fig. 2D) , were not transfected with the viral construct, providing evidence of successful stereotaxic injections specifically to the PVN. To assess the specificity of the CamKIIα promoter targeting a majority of glutamate neurons, injections of the AAV2-CamKIIα-ChR2-eYFP were performed in vGlut2-Cre mice bred with tdTomato reporter animals. Wenker et al. (2017) quantified and characterized an AAV2 transfection with the CamKIIα promoter in the C1 population of the RVLM and found it to be 60% glutamate neurons, 40% GABA and 1% glutamate/GABA coexpressing neurons (Wenker et al. 2017) . As shown in Fig. 3 , the large majority of CamKIIα-ChR2-eYFP (green) colocalized with the glutamate population (red) of PVN neurons. These data suggest that most, if not all, PVN glutamatergic neurons were transfected by AAV2-CamKIIα-ChR2-eYFP.
Lesions of PVN glutamatergic neurons
To assess the contribution of the glutamatergic population of PVN neurons to the regulation of BP at baseline and during DOCA-salt hypertension, vGlut2-Cre mice were bred with a tdTomato reporter mouse (Vong et al. 2011) . vGlut2-cre +/− /tdTomato fl/fl mice received bilateral Cre-dependent caspase (AAV-flex-taCasp3-TEVp) injections to destroy the glutamate population of neurons within the PVN. Expression of the tdTomato reporter (i.e. red fluorescence) on glutamate-positive neurons allowed quantification of lesioned neurons in experimental vs. control animals (Fig. 4) . There was a 39.3% decrease in glutamatergic neurons of the PVN relative to controls ( Fig. 4A and B ; P < 0.05), indicating a partial but significant lesion of the glutamatergic neuronal population (Fig. 4) . Figure 3C shows the distribution of glutamatergic neurons at baseline and post-lesion with the result demonstrating a greater number of glutamate neurons in the rostral portion of the nucleus than the caudal and a steady deletion throughout the PVN. Acknowledging the fact that lesioning the glutamate population of the PVN may impact the neuro-hormonal axis and glutamatergic PVN projections (primarily to the RVLM), we performed the following experiments. First, we tested circulating copeptin levels in control and lesioned groups of mice. Copeptin is the COOH-terminal fragment of the full arginine vasopressin (AVP) pro-protein. Due to its longer half-life, copeptin is more reliable as a measure of chronic AVP release (Szinnai et al. 2007) . A disruption in copeptin levels has been used as an indicator of endocrine imbalance. However, Fig. 5A shows that copeptin levels remain unchanged between lesioned and control groups, suggesting that the lesion did not alter hormonal secretion from the surrounding neurons. Additionally, Fig. 5B shows mRNA levels for genes associated with glutamatergic and GABAergic signalling. There was a small but significant rise in GluR1 mRNA expression in the RVLM (P = 0.017) after lesioning of the PVN, a gene involved in AMPA receptor expression. This increase in mRNA could suggest an up-regulation of glutamate AMPA receptors within the RVLM to offset the loss of glutamate activity in the PVN. Gene expression for Grin1, a gene involved in NMDA receptor expression, GAD67, a gene expressed in GABA neurons and the gene involved in GABA a receptor expression, remained unchanged in the RVLM between control and lesioned animals.
NE release from peripheral nerves into the circulation which is then excreted through urine can be measured as an index of sympathetic tone. To further clarify the involvement of the glutamatergic PVN neurons in the regulation of sympathetic activity at baseline and during DOCA-salt hypertension, urinary NE levels were assessed (Fig. 6A) . Lesioning of glutamatergic neurons in the PVN was associated with an unexpected rise in NE levels, suggesting that in baseline conditions, some of these PVN neurons might be involved in the inhibition of NE release. Alternatively, this increase in NE in the lesioned group at baseline could be due to compensation by other parts of the network (e.g. RVLM). As we reported previously, NE levels rose in control mice following DOCA-salt treatment (P < 0.01) supporting an increase in sympathetic activity associated with hypertension (control = 152 ± 13 ng/ml vs. DOCA = 265 ± 21 ng/ml). Interestingly, in mice with reduced numbers of glutamatergic neurons in the PVN, there was a decrease in NE with DOCA-salt treatment (115 ± 17 ng/ml, P < 0.05) compared to hypertensive controls.
The lesioned mice also showed a dramatic reduction of baroreflex sensitivity at baseline, beyond the reduction induced by DOCA-salt (P < 0.001; Fig. 6B ) supporting a role for PVN glutamatergic neurons in baroreflex modulation (Xu et al. 2015; Holbein et al. 2018) . As a possible cause for this large baroreflex sensitivity change, we assessed whether the glutamatergic PVN lesion led to inflammation in the RVLM. We chose the RVLM because, in addition to being a large target of PVN projections, it is a critical region involved in the baroreceptor reflex (Wu et al. 2012) . However, although changes in TNFα signalling are commonly associated with inflammation in the CNS, our western blot analysis showed that the inflammatory marker TNFα-R1 did not change in the RVLM between control and lesion cohorts of mice (P = 0.29), suggesting that inflammation might not be responsible for the altered baroreflex sensitivity (Fig. 7) . In control mice, DOCA-salt treatment induced a robust hypertension with a BP that remained elevated over 2 weeks (MAP increase = 36.3 ± 1.9 mmHg, P < 0.001). In mice with lesioned glutamatergic neurons in the PVN, baseline BP showed a trend to rise but this failed to reach significance. Moreover, DOCA-salt treatment only produced an attenuated pressor response (Fig. 8A ) in these mice suggesting that PVN glutamatergic neurons are necessary for the development of DOCA-salt hypertension.
Discussion
The current study provides new evidence for the requirement of PVN glutamatergic neurons in the development of neurogenic hypertension in conscious mice. When these PVN neurons are directly photo-activated in conscious mice there is a frequencydependent increase in BP. Additionally, in a separate experiment, mice with glutamate neurons lesioned from the PVN show an attenuated hypertension and no increase in urinary noradrenaline levels under DOCA-salt treatment.
The stimulation of PVN neurons at baseline causing an immediate increase in BP indicates this neuronal population is sufficient to promote an elevation of BP (Fig. 1) . This rise in BP is likely caused by an increase in . Urine noradrenaline (NE) levels A, urine was collected from vGlut2-Cre mice that had previously received bilateral AAV-flex-taCasp3-TEVp to the PVN (lesioned mice) and wildtype controls before and 21 days after DOCA-salt treatment. DOCA treatment significantly increased NE levels in control mice. Lesioned mice had higher NE at baseline and lower values after DOCA treatment. There was no difference between control mice at baseline and Lesion + DOCA mice. B, spontaneous baroreceptor reflex sensitivity (SBRS) was measured in control or lesioned animals at baseline and after DOCA-salt treatment. A, n = 16 control, n = 8 lesion; B, n = 19 control, n = 7 lesion; * P < 0.05, * * P < 0.01, * * * P < 0.001 (Kruskal-Wallis test and Dunn's multiple comparison test). sympathetic drive. ChR2 stimulation causes a rapid BP increase (<0.5 s) indicating a CNS-mediated activation. The speed of BP increase rules out a hormonal (i.e. vasopressin) source of BP rise, which would act in the order of minutes (Yamaguchi, 2015) . Secondly, partial lesioning of the glutamate population within the PVN resulted in a less dramatic rise in BP and prevented the increase of NE levels during hypertension, indicating that this excitatory neuronal population may be overactive during neurogenic hypertension.
Sham
PVN and its role in BP regulation
It has long been hypothesized that the convergence of inputs from multiple brain regions involved in BP regulation, ranging from the forebrain to the hindbrain, onto the PVN and its projections to the RVLM and intermediolateral (IML) column makes this nucleus an ideal hub for sympathetic nervous system integration and regulation. Whether PVN neurons contribute to BP regulation at baseline and to what extent in conscious animals is still debated (Callahan et al. 1992; Ramchandra et al. 2013; Steckelings et al. 2017) . However, it is generally accepted that the pre-sympathetic glutamate population of PVN neurons is tonically inhibited by upstream GABAergic inputs from other regions (Cullinan et al. 2008) . Martins-Pinge et al. (2012) showed in conscious rats that had received microinjections of kynurenic acid a marginal BP decrease and a significantly increased BP during GABA blockade (Martins-Pinge et al. 2012) . Moreover, Park et al. (2007) showed through patch-clamp experiments that there is the 'presence of a persistent GABA(A)-mediated inhibitory modality in pre-sympathetic PVN neurons, which plays a major role in modulating their excitability and firing activity' (Park et al. 2007) . The role of the glutamatergic neuronal population in the PVN during the development and maintenance of hypertension has become increasingly evident in recent studies. Li & Pan (2017) recently reviewed the increased activation of glutamate receptors in the PVN both pre-and postsynaptically in multiple hypertension models. These authors emphasized the importance of plasticity of the glutamatergic population, specifically the NMDA receptors, within the PVN, during the development of hypertension. These changes result in an increased sympathetic drive that potentiates neurogenic hypertension. Our findings, examining the role of the glutamatergic population of the PVN before and during neurogenic hypertension, support this theory. Here we show for the first time that in conscious mice the glutamatergic population of neurons of the PVN is sufficient to drive BP when stimulated and it may be through this chronic over-activation that neurogenic hypertension is produced and maintained.
Unlike other approaches, ChR2 measures the instantaneous contribution of the transfected neuronal population with little to no homeostatic compensation. ChR2 allowed us to entrain this population of neurons with stimulations ranging from 2-20 Hz, obtaining the full range of physiological levels of firing for these neurons (Chen & Toney, 2010; Abbott et al. 2014) . Our results show that unilateral stimulation of the CamKIIα-expressing neuronal population of the PVN, which we highlighted as being mostly glutamatergic (Fig. 3) , is enough to cause a significant rise in BP in a frequency-dependent manner. Wang et al. (2013) showed in recent studies, and we confirm here with current histological analysis, that glutamatergic neurons of the C, heart rate in beats per minute (BPM) at days −1, 7 and 14. n = 9 control, n = 8 lesion; * P < 0.05, * * P < 0.01, * * * P < 0.001 (two-way ANOVA).
PVN can be selectively transfected (Wang et al. 2013; Watakabe et al. 2015) . Through stereotaxic injection and histological analysis, we confirm that the PVN alone is transfected with the AAV2-CamKII-ChR2-eYFP and not surrounding nuclei (e.g. SFO and arcuate nuclei). We speculate that this transfected population of neurons has the potential to cause an even greater increase in BP if the entire bilateral glutamatergic population were to be chronically over-excited, as is hypothesized in neurogenic hypertension.
Disease state-dependent control of BP by the PVN
Increased BP can be elicited by stimulation of the PVN or its downstream targets, such as the RVLM (Abbott et al. 2009; Martins-Pinge et al. 2012; Burke et al. 2014; Li & Pan, 2017) . When sympathetic outflow from the RVLM is inhibited through optogenetics, BP decreases (Basting et al. 2015) . The present study adds three novel insights into this sympatho-excitatory pathway. First, stimulation of a subset of the excitatory pre-sympathetic neurons of the PVN in conscious mice causes an immediate rise in BP (Liu & Jones, 1996; Watakabe et al. 2015) . Second, partial lesioning of the glutamatergic population of the PVN does not cause a significant change of baseline BP though NE levels do rise. However, throughout the development of hypertension these changes are reversed. Within the first week, mice on the DOCA-salt protocol, that had received bilateral lesions of the glutamatergic neurons of the PVN, exhibited a blunted rise in BP compared to control animals. Additionally, urinary NE levels in lesioned mice dropped down to levels equivalent to control animals at baseline. Third, through vGlut2-tdTomato-positive neuronal cell counts, we documented that there is an uneven distribution of vGlut2-positive neurons throughout the PVN, with the rostral PVN containing more vGlut2-positive neurons than that of the caudal portion (Fig. 4) . Further investigation is needed to identify the functional connectome of these cells. The PVN sends reciprocal connections to the RVLM in addition to innervating the IML (Chen & Toney, 2010) . This connection has been shown to play multiple roles, one of which is maintaining a healthy baroreflex (Holbein et al. 2018) . After lesioning this population of neurons, we observed a severe impairment of this reflex (Fig. 6B ) that has been shown to exacerbate the pathogenesis of neurogenic hypertension (Ketch et al. 2002) . Also, lesioning the glutamatergic population of the PVN resulted in an increased mRNA expression of GluR1, a gene involved in AMPA receptor regulation in the RVLM suggesting a possible compensatory action by the brainstem. The increased activity of the PVN observed in both ChR2 experiments and throughout the DOCA-salt protocol is reasonably causing these populations of neurons to become more excitable themselves. These connections contribute to the pronounced increase of sympathetic nerve activity in hypertension (Guyenet, 2006; Ye et al. 2013; Basting & Lazartigues, 2017) .
Experimental limitations
AAV2-CamKIIα-ChR2 transduces a mixed population of neurons though preferentially targets glutamatergic neurons, as described previously (Liu & Jones, 1996; Watakabe et al. 2015) and confirmed here. However, in the ChR2 experiments, selective stimulation of the transduced cell population resulted in an immediate rise in BP, returned to pre-stimulated values within 30 s of the laser being turned off, and did not cause any observable behavioural changes, indicating that the stimulatory effects were most plausibly neurogenic, as opposed to hormonal.
For both the stimulation and the lesion experiments utilizing the CamKIIα-ChR-eYFP and the flex-taCasp3-TEVp, respectively, our aim was to target the PVN specifically. There is a chance that the viruses could have been taken up by nerve terminals and been expressed in afferent connections. After histology and quantification of the lesions it is clear that specific transfection to the PVN was achieved through the combination of precise stereotaxic injections and optrode placement but did not transduce every neuron of interest. It is highly probable that if 100% of glutamatergic neurons were transfected bilaterally the effects seen would increase significantly.
Novelty and significance
To measure the contribution of excitatory neurons of the PVN to BP in conscious mice, we used two different approaches. First, gain-of-function optogenetics experiments utilizing ChR2 were performed. PVN neurons were transduced unilaterally to express the photoactivatable cation channels allowing us to observe the instantaneous contribution of the transfected cell population in conscious animals. Secondly, we used a Cre-dependent caspase that was virally delivered to selectively lesion the glutamatergic neuronal population of the PVN. These animals then underwent a DOCA-salt protocol that is a well-established model of neurogenic hypertension (Basting & Lazartigues, 2017) . Studies shown here allowed us to investigate the roles of similar sets of neurons in the PVN under different experimental conditions through monitoring BP, heart rate, baroreflex, copeptin and NE levels.
Perspectives
The present study could help explain why many forms of hypertension are exacerbated by high-salt diets, dehydration and chronic stress. During periods of prolonged exposure to high-salt diets, dehydration and stressors, animals and humans show an increase in BP (Vivas et al. 2014; Holbein & Toney, 2015) . Salt-sensing and thirst are both mediated either directly or indirectly by the PVN or areas that are relaying that information to the PVN (e.g. SFO and median preoptic nucleus) (Speth et al. 2014; Vivas et al. 2014) . Stress has been shown to increase components of the renin-angiotensin system, such as angiotensin II and decrease beneficial components, such as angiotensin-converting enzyme 2 (ACE2) in the hypothalamus (Sriramula et al. 2011; Martins Lima et al. 2013; Xia et al. 2015) . Recurrent periods of over-excitation in the PVN could contribute to chronic over-activation of this nucleus and thus enhanced sympathetic drive.
